German Spondyloarthritis Inception Cohort (GESPIC)
Sponsor: AbbVie
A observational or N/A phase clinical study on Acute Anterior Uveitis (AAU) and Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), this trial is actively recruiting participants. The trial is conducted by AbbVie and has accumulated 11 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2021 — Jul 2024 [monthly]
Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Oct 2019 — Feb 2020 [monthly]
Recruiting
-
Feb 2019 — Oct 2019 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie
- Amgen
- Berlin Institute of Health
- Centocor, Inc.
- Charite University, Berlin, Germany
- German Federal Ministry of Education and Research
- Novartis
- Schering-Plough
- UCB Pharma
- Wyeth is now a wholly owned subsidiary of Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .